You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

CLAFORAN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Claforan, and when can generic versions of Claforan launch?

Claforan is a drug marketed by Sanofi Aventis Us and Sterimax and is included in three NDAs.

The generic ingredient in CLAFORAN is cefotaxime sodium. There are fourteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the cefotaxime sodium profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for CLAFORAN?
  • What are the global sales for CLAFORAN?
  • What is Average Wholesale Price for CLAFORAN?
Summary for CLAFORAN
Drug patent expirations by year for CLAFORAN
Recent Clinical Trials for CLAFORAN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
HÃ¥kan HanbergerPhase 4
University Medical Center GroningenPhase 4
University of California, San FranciscoPhase 1

See all CLAFORAN clinical trials

US Patents and Regulatory Information for CLAFORAN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sanofi Aventis Us CLAFORAN cefotaxime sodium INJECTABLE;INJECTION 062659-001 Jan 13, 1987 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sterimax CLAFORAN IN DEXTROSE 5% IN PLASTIC CONTAINER cefotaxime sodium INJECTABLE;INJECTION 050596-002 May 20, 1985 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sterimax CLAFORAN cefotaxime sodium INJECTABLE;INJECTION 050547-003 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sterimax CLAFORAN IN DEXTROSE 5% IN PLASTIC CONTAINER cefotaxime sodium INJECTABLE;INJECTION 050596-004 May 20, 1985 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.